Compositions inhibiting murine MXT ductal carcinoma

Details Compositions inhibiting murine MXT ductal carcinoma Compositions inhibiting murine MXT ductal carcinoma

1986-02-03

1987-05-26

Schenkman, Leonard

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

A61K 3156

Patent

active

046686681

ABSTRACT:
A compound of the formula ##STR1## wherein Z is alkoxy of 1-4 carbon atoms and Y is amino, inhibits the growth of murine ductal carcinoma (MXT mammary tumors). A compound wherein Z is OH and Y is nitro, administered orally, inhibits the growth of MXT mammary tumors.

REFERENCES:
patent: 3377362 (1968-04-01), Cantrall et al.
patent: 3526648 (1970-09-01), Bertin et al.
patent: 4340602 (1982-07-01), Brooks
patent: 4496555 (1985-01-01), Brooks et al.
patent: 4522758 (1985-06-01), Ward et al.
Rozhin et al, "Proc. Am. Assoc. Cancer Research", No. 21 (1980), p. 260.
Rozhin et al, Cancer Res., 43:2611-2617 (Jun., 1983).
Neeman et al, J. Med. Chem., 1983:465-469 (1983).
Utne et al, J. Org. Chem., 33:2469-2473 (1968).
Iyer et al, J. Org. Chem., 47:644 (1982).
Iyer et al, J. Med. Chem., 28:162 (1983).
Brooks et al, J. Toxic. and Environ. Health, 4:283-300 (1978).
Rozhin et al, J. Biol. Chem., 252:7214-7220 (1977).
Pack et al, Endocrinology, 95:1680-1690 (1974).

Affiliated with

Also associated with

Rating

Compositions inhibiting murine MXT ductal carcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions inhibiting murine MXT ductal carcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions inhibiting murine MXT ductal carcinoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-703932